We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+1.26%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$4.8B
AUM Growth
-$159M
Cap. Flow
-$187M
Cap. Flow %
-3.89%
Top 10 Hldgs %
18.32%
Holding
695
New
64
Increased
242
Reduced
263
Closed
62

Top Sells

Rank Stock Value
1
EWJ icon
iShares MSCI Japan ETF
EWJ
+$40.8M
2
INTU icon
Intuit
INTU
+$32.8M
3
META icon
Meta Platforms (Facebook)
META
+$30.3M
4
MA icon
Mastercard
MA
+$28.3M
5
NKE icon
Nike
NKE
+$25.9M

Sector Composition

Rank Sector Weight
1 Healthcare 29.43%
2 Financials 13.37%
3 Technology 9.86%
4 Consumer Discretionary 7.77%
5 Industrials 7.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
COR icon
301
Cencora
COR
$60.3B
$3.11M 0.06%
29,226
+1,006
+4% +$113K
DHR icon
302
Danaher
DHR
$135B
$3.08M 0.06%
53,596
-153,647
-74% -$8.8M
BKNG icon
303
Booking.com
BKNG
$138B
$3.06M 0.06%
66,500
+15,100
+29% +$720K
PNW icon
304
Pinnacle West Capital
PNW
$12.9B
$3.06M 0.06%
+53,790
New +$3.24M
BDX icon
305
Becton Dickinson
BDX
$43.1B
$3.03M 0.06%
21,936
+2,444
+13% +$337K
LUMN icon
306
Lumen
LUMN
$6.53B
$3M 0.06%
102,026
-580
-0.6% -$19.8K
HAS icon
307
Hasbro
HAS
$12.6B
$2.94M 0.06%
39,314
-13,425
-25% -$957K
DD icon
308
DuPont de Nemours
DD
$18.6B
$2.94M 0.06%
22,659
-78,571
-78% -$10.2M
TU icon
309
Telus
TU
$16B
$2.91M 0.06%
168,940
+49,050
+41% +$842K
INFI
310
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$2.9M 0.06%
265,000
RRC icon
311
Range Resources
RRC
$9.11B
$2.9M 0.06%
58,749
+4,150
+8% +$237K
CNQ icon
312
Canadian Natural Resources
CNQ
$96.9B
$2.88M 0.06%
219,704
+17,309
+9% +$261K
CTIC
313
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$2.82M 0.06%
144,500
CNI icon
314
Canadian National Railway
CNI
$78.3B
$2.81M 0.06%
48,726
+1,284
+3% +$80.4K
AVDL
315
DELISTED
Avadel Pharmaceuticals
AVDL
$2.8M 0.06%
132,000
-76,000
-37% -$1.36M
LEG icon
316
Leggett & Platt
LEG
$1.52B
$2.79M 0.06%
57,374
+552
+1% +$25.8K
APD icon
317
Air Products & Chemicals
APD
$66.3B
$2.78M 0.06%
21,967
+18,377
+512% +$2.51M
EGN
318
DELISTED
Energen
EGN
$2.77M 0.06%
40,554
+3,495
+9% +$243K
USB icon
319
US Bancorp
USB
$99.6B
$2.76M 0.06%
63,605
-563
-0.9% -$24.6K
AMT icon
320
American Tower
AMT
$77.7B
$2.59M 0.05%
27,783
+8,100
+41% +$766K
WEC icon
321
WEC Energy
WEC
$37.7B
$2.58M 0.05%
57,465
+49,465
+618% +$2.37M
MACK
322
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$2.41M 0.05%
+24,785
New +$2.36M
ACOR
323
DELISTED
Acorda Therapeutics
ACOR
$2.4M 0.05%
+600
New +$2.32M
UPS icon
324
United Parcel Service
UPS
$97.6B
$2.4M 0.05%
24,760
-2,692
-10% -$267K
SPG icon
325
Simon Property Group
SPG
$74.5B
$2.4M 0.05%
13,859
+514
+4% +$94.5K

Similar funds

Candriam SCA's Q2 2015 Portfolio in Review

As of Q2 2015, Candriam SCA held 695 positions worth $4.8B, down 3.2% from $4.96B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Candriam SCA withdrew a net $187M in Q2 2015, closing 62 positions and reducing 263 holdings. Its most notable exit was iShares MSCI Japan ETF, an estimated $40.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, up from 28% a quarter earlier, followed by Financials and Technology.

Against the trend, Candriam SCA opened a new position in American Airlines Group worth $11.6M.

  • Candriam SCA's largest Q2 2015 buy was American Airlines Group: 290,014 shares worth $11.6M.
  • Candriam SCA added most to Alphabet (Google) Class C in Q2 2015, an estimated $33.8M increase.
  • Candriam SCA's biggest Q2 2015 reduction was Intuit, cutting an estimated $32.8M.
  • Candriam SCA fully exited iShares MSCI Japan ETF in Q2 2015, selling an estimated $40.8M.
  • Candriam SCA's ten largest holdings make up 18% of its $4.8B portfolio in Q2 2015.
  • Candriam SCA opened 64 new positions and closed 62 in Q2 2015.
  • Candriam SCA's portfolio value fell 3.2% quarter-over-quarter to $4.8B.

Based on Candriam SCA's 13F filing for Q2 2015, filed 29 Jul 2015.